<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01304134</url>
  </required_header>
  <id_info>
    <org_study_id>OXYI09-CN-302</org_study_id>
    <nct_id>NCT01304134</nct_id>
  </id_info>
  <brief_title>Oxycodone Hydrochloride Injection in the Postoperative Pain Relieving Treatment</brief_title>
  <official_title>A Prospective, Randomized, Blind, Multicentre, Parallel Group Study to Investigate the Efficacy and Safety of Oxycodone Hydrochloride Injection in the Postoperative Pain Relieving Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mundipharma (China) Pharmaceutical Co. Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mundipharma (China) Pharmaceutical Co. Ltd</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the efficacy and safety of oxycodone i.v. patient-controlled analgesia (PCA) in
      the pain relieving treatment during 48h postoperative period, by comparing with morphine i.v.
      PCA.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">August 2010</completion_date>
  <primary_completion_date type="Actual">August 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measuring VAS</measure>
    <time_frame>3h post-operation</time_frame>
    <description>Measuring resting and coughing VAS, assessing the intensity of pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measuring VAS</measure>
    <time_frame>24 hours post operation</time_frame>
    <description>Measuring resting and coughing VAS, assessing the intensity of pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measuring VAS</measure>
    <time_frame>48 hours post operation</time_frame>
    <description>Measuring resting and coughing VAS, assessing the intensity of pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dosage</measure>
    <time_frame>Within 48h</time_frame>
    <description>Total dosage of study drugs within 48h.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The dosage of other rescue analgesic drugs used within 48h post-operation.</measure>
    <time_frame>48hrs</time_frame>
    <description>The dosage of other rescue analgesic drugs used within 48h post-operation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The invalid times and the total times of PCA application</measure>
    <time_frame>48hrs</time_frame>
    <description>The invalid times and the total times of PCA application</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction degree for analgesia</measure>
    <time_frame>48hrs</time_frame>
    <description>Satisfaction degree for analgesia after the treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AE occurrence and abnormal lab value</measure>
    <time_frame>48hrs</time_frame>
    <description>AE and normal lab value will be recorded during the study</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">240</enrollment>
  <condition>Other Acute Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Oxycodone i.v.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>To determine the efficacy and safety of oxycodone i.v. patient-controlled analgesia (PCA)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Morphine i.v.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>To determine the efficacy and safety of oxycodone i.v. patient-controlled analgesia (PCA)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxycodone</intervention_name>
    <description>dosage:10mg/l dosage form:injection frequency:via PCA pump, background rate:0.5ml/h, 2ml/time duration:48 hours</description>
    <arm_group_label>Oxycodone i.v.</arm_group_label>
    <other_name>Oxycodone Injection</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>dosage: 10mg/ml dosage form: injection frequency: via PCA pump, background rate: 0.5ml/h, 2ml/times duration: 48 hours</description>
    <arm_group_label>Morphine i.v.</arm_group_label>
    <other_name>Morphine Injection</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients of either sex aged 18 to 65 years old, with a standard body weight [standard
             body weight = height (cm) - 100] ±15%.

          2. ASA I and II.

          3. Scheduled on elective open upper abdominal surgery under general anesthesia (liver,
             gall bladder, spleen, stomach, kidney, colon surgery), of which predicted operation
             duration is between 2-4h.

          4. Hospitalized patients on non-emergency condition who have been given appropriate
             preoperative treatments.

          5. Patients who are willing to participate in the study and have signed the written
             informed consent.

          6. Negative pregnancy test result should be obtained for women of child-bearing age.

        Exclusion Criteria:

          1. Long-term analgesics or psychotropic drugs (including opioids, NSAIDs, sedatives,
             antidepressants) taken for the chronic pain, or patients abusing alcohol.

          2. Body weight is less than or over ±15% of the standard body weight.

          3. Severe impairment of liver and renal function at preoperative stage (ALT, AST, BUN,
             Cr).

          4. Medical history of recovering from abnormal surgery anesthesia.

          5. Medical history of hypertension (Systolic blood pressure ≥180Hg, Diastolic blood
             pressure 110Hg).

          6. Esophagus reflux disease.

          7. Sedatives, anti-emetics, and anti-pruritic drugs were taken 24 hours before operation.

          8. Have known hypersensitivity to opioids.

          9. Monoamine oxidase inhibitors and antidepressant drugs were taken within 15 days.

         10. Patients with shock.

         11. Patients with COPD.

         12. Patients can not understand the VAS or unable to use PCA.

         13. Pregnant or parturient women.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mundipharma China Ltd.</last_name>
    <role>Study Chair</role>
    <affiliation>Mundipharma China Ltd.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mundipharma China Ltd.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Investigational Site Beijing, China</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Investigational site</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100022</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 23, 2011</study_first_submitted>
  <study_first_submitted_qc>February 23, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2011</study_first_posted>
  <last_update_submitted>August 10, 2015</last_update_submitted>
  <last_update_submitted_qc>August 10, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 11, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Oxycodone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

